RAD 3.45% 2.8¢ radiopharm theranostics limited

RAD media and Publications, page-164

  1. 1,211 Posts.
    lightbulb Created with Sketch. 1726
    Cash flow is always a problem as a single person in a trial can cost up to hundreds of thousands of dollars and trials aren't run in 5 minutes if you are after a cancer inhibitor or better still, a cure. How long is needed to find out if one of these things works? Add on the cost of development with top medical/scientific brains running research labs and I'm not surprised we used up millions last quarter. I just bought in for the first time. I'm happy to support something with the potential to change cancer treatment for the betterment of mankind, and RAD has some very promising molecules.
    I'm not interested in any valuation so called analysts place on the company. If one of their therapeutics or diagnostics gets commercialised you can throw those valuations out the window.
 
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.